Klabax

Clarithromycin, the active ingredient in Klabax, is a macrolide antibiotic presented as an oral dosage form for oral use. It treats a range of bacterial infections including pneumonia, sinusitis, bronchitis exacerbations, skin infections and is used in Helicobacter pylori eradication regimens. GNH USA supplies Klabax as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Clarithromycin is employed to treat bacterial infections affecting the respiratory tract, skin and gastrointestinal system. - Community‑acquired pneumonia: eradicates the causative bacteria and improves clinical recovery. - Acute bacterial sinusitis: reduces sinus inflammation and clears infection. - Acute bacterial exacerbations of chronic bronchitis: shortens symptom duration and prevents complications. - Skin and soft‑tissue infections: eliminates pathogenic bacteria and promotes wound healing. - Helicobacter pylori eradication regimens: contributes to bacterial clearance when combined with other agents.

Clarithromycin may cause a variety of adverse reactions, ranging from mild to severe.

Common Side Effects: - Nausea: mild to moderate upset stomach. - Diarrhea: loose stools, sometimes watery. - Abdominal pain: cramping or discomfort. - Taste disturbance: metallic or bitter taste. - Headache: mild tension‑type headache. - Rash: mild skin erythema or itching.

Serious or Rare Side Effects: - Hepatotoxicity: elevated liver enzymes or jaundice. - QT prolongation: cardiac rhythm disturbances. - Severe allergic reaction: anaphylaxis or angioedema. - Clostridioides difficile colitis: severe diarrhea with abdominal pain.

Before prescribing Klabax, clinicians should consider patient‑specific factors and monitoring requirements. - Assess liver function: avoid use in severe hepatic impairment. - Review cardiac history: caution in patients with known QT prolongation. - Evaluate drug interactions: check concomitant medications that affect CYP3A4. - Monitor renal function: dose adjustment may be needed in severe renal failure. - Pregnancy and lactation: use only if benefits outweigh potential risks. - Store at ambient temperature: keep below 25°C in the original container, protect from moisture and light.

Clarithromycin interacts with several drug classes, requiring careful management.

Major Interactions (Avoid): - Statins metabolized by CYP3A4 (e.g., simvastatin, lovastatin): risk of rhabdomyolysis. - Certain antiarrhythmics (e.g., amiodarone, quinidine): may cause serious QT prolongation. - Pimozide: increased plasma levels leading to neurotoxicity.

Moderate Interactions (Monitor Closely): - Warfarin: enhanced anticoagulant effect, monitor INR. - Oral hypoglycemics (e.g., sulfonylureas): potential hypoglycemia, monitor glucose. - Anticonvulsants (e.g., carbamazepine, phenytoin): may reduce clarithromycin levels.